Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M95.0Revenue $M1.7Net Margin (%)-1,110.9Altman Z-Score-8.4
Enterprise Value $M71.0EPS $-0.7Operating Margin %-1,122.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-12.1Pre-tax Margin (%)-1,120.8Higher ROA y-yN
Price/Book5.010-y EBITDA Growth Rate %--Quick Ratio8.4Cash flow > EarningsY
Price/Sales53.35-y EBITDA Growth Rate %--Current Ratio8.4Lower Leverage y-yY
Price/Free Cash Flow9.7y-y EBITDA Growth Rate %-269.4ROA % (ttm)-53.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-69.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)-2,444.8Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PSDVKen Fisher 2015-09-30 Buy $3.49 - $4.47
($3.92)
$ 3.20-18%New holding12,057
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PSDV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Leonard SVice President, Finance 2016-01-04Sell5,000$4.7-31.91view
Ross Leonard SVice President, Finance 2015-12-22Sell33,950$5.39-40.63view
Ashton PaulPresident & CEO 2015-12-22Sell120,000$5.39-40.63view
Ross Leonard SVice President, Finance 2015-12-01Sell1,050$4.06-21.18view
Ross Leonard SVice President, Finance 2015-08-03Sell5,000$4.05-20.99view
Ashton PaulPresident & CEO 2014-10-01Sell10,000$4.27-25.06view
Ashton PaulPresident & CEO 2014-09-02Sell10,000$4.78-33.05view
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.37-26.77view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.32-25.93view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$4-20view

Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    Weekly CEO Sales Highlight: pSivida Corp., Equity Residential, Ciena Corp., Sabre Corp. Dec 28 2015 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 

    More From Other Websites
    pSivida Corp Earnings Call scheduled for 4:30 pm ET today Feb 08 2016
    PSivida reports 2Q loss Feb 08 2016
    PSivida reports 2Q loss Feb 08 2016
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 08 2016
    pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results Feb 08 2016
    Q2 2016 pSivida Corp Earnings Release - After Market Close Feb 08 2016
    pSivida Corp Announces Second Quarter Fiscal Year 2016 Financial Results Release Date and Conference... Feb 01 2016
    pSivida Corp Announces Second Quarter Fiscal Year 2016 Financial Results Release Date and Conference... Feb 01 2016
    pSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9 Jan 28 2016
    pSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9 Jan 28 2016
    pSivida Closes $17.8 Million Offering Jan 13 2016
    pSivida Closes $17.8 Million Offering Jan 13 2016
    PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 08 2016
    pSivida Announces Pricing of $16 Million Public Offering of Common Stock Jan 07 2016
    pSivida Announces Pricing of $16 Million Public Offering of Common Stock Jan 07 2016
    pSivida Announces Proposed Public Offering of Common Stock Jan 06 2016
    pSivida Announces Proposed Public Offering of Common Stock Jan 06 2016
    pSivida shares hit new high on plans to file for European drug approval Dec 28 2015
    pSivida Plans Medidur™ EU Marketing Approval Application Based on Single Phase 3 Clinical Trial Dec 28 2015
    pSivida Plans Medidur™ EU Marketing Approval Application Based on Single Phase 3 Clinical Trial Dec 28 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK